drugset / Trial / NCT02272660

Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip Arthroplasty

NCT02272660

Phase 4 Completed 74 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluated the effect of perioperative parecoxib administration on postoperative pain, analgesic use, function recovery, inflammatory response and bleeding risk.

Timeline

Start
2014-10
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Parecoxib Small molecule 40 mg

Indications